Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Tesa SE

Division of Beiersdorf AG

Latest From Alpharma USPD

Asia On The Move: Takeda Names Senior Leadership, CDE Hires Reviewer, Simcere CSO Departs

Takeda reorganized several key pharmaceutical businesses, including a new Global Marketing Center. China’s drug review authority, the Center for Drug Evaluation, hired a new reviewer with a FDA background and is actively recruiting for more open positions.

BioPharmaceutical China

Deals Shaping the Medical Industry (6/07)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Dermatology
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • Beiersdorf AG
  • Senior Management
  • Thomas Schlegel, CEO
    Jan Christoph Teetz, CFO
  • Contact Info
  • Tesa SE
    Phone: (49) 40 4909 4448
    Quickbornstr. 24
    Hamburg, 20253